Terms: = Prostate cancer AND ARNT, HIF1BETA, 405, ENSG00000143437, P27540, HIF-1beta, HIF1B, TANGO AND Treatment
58 results:
1. PSA-density, DRE, and PI-RADS 5: potential surrogates for omitting biopsy?
Falkenbach F; Ambrosini F; Kachanov M; Ortner G; Maurer T; Köhler D; Beyersdorff D; Graefen M; Budäus L
World J Urol; 2024 Mar; 42(1):182. PubMed ID: 38506941
[TBL] [Abstract] [Full Text] [Related]
2. Light-responsive smart nanocarriers for wirelessly controlled photodynamic therapy for prostate cancers.
Sun B; Liu J; Kim HJ; Rahmat JNB; Neoh KG; Zhang Y
Acta Biomater; 2023 Nov; 171():553-564. PubMed ID: 37739246
[TBL] [Abstract] [Full Text] [Related]
3. Comprehensive geriatric assessment predicts radiation-induced acute toxicity in prostate cancer patients.
Paal K; Stranz B; Thurner EM; Langsenlehner U; Renner W; Brunner TB; Langsenlehner T
Strahlenther Onkol; 2024 Mar; 200(3):208-218. PubMed ID: 37658924
[TBL] [Abstract] [Full Text] [Related]
4. Intensity-modulated radiation therapy for intermediate-risk prostate cancer: does ADT still have an impact in the dose-escalated external beam radiation therapy era?
Soyano T; Kozuka T; Kashihara K; Murakami Y; Yonese J; Sasamura K; Shimoyachi N; Kashihara T; Yoshioka Y; Oguchi M
Jpn J Clin Oncol; 2023 Jun; 53(6):514-521. PubMed ID: 36946312
[TBL] [Abstract] [Full Text] [Related]
5. "Time" for obesity-related cancer: The role of the circadian rhythm in cancer pathogenesis and treatment.
Miro C; Docimo A; Barrea L; Verde L; Cernea S; Sojat AS; Marina LV; Docimo G; Colao A; Dentice M; Muscogiuri G
Semin Cancer Biol; 2023 Jun; 91():99-109. PubMed ID: 36893964
[TBL] [Abstract] [Full Text] [Related]
6. Mendelian randomization and clinical trial evidence supports TYK2 inhibition as a therapeutic target for autoimmune diseases.
Yuan S; Wang L; Zhang H; Xu F; Zhou X; Yu L; Sun J; Chen J; Ying H; Xu X; Yu Y; Spiliopoulou A; Shen X; Wilson J; Gill D; Theodoratou E; Larsson SC; Li X
EBioMedicine; 2023 Mar; 89():104488. PubMed ID: 36842216
[TBL] [Abstract] [Full Text] [Related]
7. LncRNA H19 promotes tumor angiogenesis in smokers by targeting anti-angiogenic miRNAs.
Shirvaliloo M
Epigenomics; 2023 Jan; 15(2):61-73. PubMed ID: 36802727
[TBL] [Abstract] [Full Text] [Related]
8. Why arnt prostate Tumors Responding to Enzalutamide?
Zhang M; Moreno-Rodriguez T; Quigley DA
Cancer Discov; 2022 Sep; 12(9):2017-2019. PubMed ID: 36052502
[TBL] [Abstract] [Full Text] [Related]
9. A human antibody against human endothelin receptor type A that exhibits antitumor potency.
Ju MS; Ahn HM; Han SG; Ko S; Na JH; Jo M; Lim CS; Ko BJ; Yu YG; Lee WK; Kim YJ; Jung ST
Exp Mol Med; 2021 Sep; 53(9):1437-1448. PubMed ID: 34588605
[TBL] [Abstract] [Full Text] [Related]
10. Apalutamide in Patients With Metastatic Castration-Sensitive prostate cancer: Final Survival Analysis of the Randomized, Double-Blind, Phase III TITAN Study.
Chi KN; Chowdhury S; Bjartell A; Chung BH; Pereira de Santana Gomes AJ; Given R; Juárez A; Merseburger AS; Özgüroğlu M; Uemura H; Ye D; Brookman-May S; Mundle SD; McCarthy SA; Larsen JS; Sun W; Bevans KB; Zhang K; Bandyopadhyay N; Agarwal N
J Clin Oncol; 2021 Jul; 39(20):2294-2303. PubMed ID: 33914595
[TBL] [Abstract] [Full Text] [Related]
11. Therapeutic effect of thalidomide combined with temozolomide and three-dimensional conformal radiotherapy for patients with high-grade gliomas after operation.
Sui L; Li Y; Xu Z; Shen X
J BUON; 2021; 26(1):2608-2615. PubMed ID: 33721435
[TBL] [Abstract] [Full Text] [Related]
12. Testosterone Therapy After prostate cancer treatment: A Review of Literature.
Natale C; Carlos C; Hong J; Khera M; Baum N; Raheem OA
Sex Med Rev; 2021 Jul; 9(3):393-405. PubMed ID: 33516741
[TBL] [Abstract] [Full Text] [Related]
13. An organoid-based drug screening identified a menin-MLL inhibitor for endometrial cancer through regulating the HIF pathway.
Chen J; Zhao L; Peng H; Dai S; Quan Y; Wang M; Wang J; Bi Z; Zheng Y; Zhou S; Liu Y; Chen C; Na F
Cancer Gene Ther; 2021 Feb; 28(1-2):112-125. PubMed ID: 32632269
[TBL] [Abstract] [Full Text] [Related]
14. Association between depression and healthcare expenditures among elderly cancer patients.
Gu D; Morgan RO; Li R; Weber ES; Shen C
BMC Psychiatry; 2020 Mar; 20(1):131. PubMed ID: 32293366
[TBL] [Abstract] [Full Text] [Related]
15. Does Time Spent on Active Surveillance Adversely Affect the Pathological and Oncologic Outcomes in Patients Undergoing Delayed Radical prostatectomy?
Ahmad AE; Richard PO; Leão R; Hajiha M; Martin LJ; Komisarenko M; Grewal R; Goldberg H; Salem S; Jain K; Oliaei A; Horyn I; Timilshina N; Zlotta A; Hamilton R; Kulkarni G; Fleshner N; Alibhaic SMH; Finelli A
J Urol; 2020 Sep; 204(3):476-482. PubMed ID: 32259466
[TBL] [Abstract] [Full Text] [Related]
16. Performance of clinicopathologic models in men with high risk localized prostate cancer: impact of a 22-gene genomic classifier.
Tosoian JJ; Birer SR; Jeffrey Karnes R; Zhang J; Davicioni E; Klein EE; Freedland SJ; Weinmann S; Trock BJ; Dess RT; Zhao SG; Jackson WC; Yamoah K; Dal Pra A; Mahal BA; Morgan TM; Mehra R; Kaffenberger S; Salami SS; Kane C; Pollack A; Den RB; Berlin A; Schaeffer EM; Nguyen PL; Feng FY; Spratt DE
Prostate Cancer Prostatic Dis; 2020 Dec; 23(4):646-653. PubMed ID: 32231245
[TBL] [Abstract] [Full Text] [Related]
17. Predictive Factors of the Risk of Long-Term Hospital Readmission after Primary prostate Surgery at a Single Tertiary Referral Center: Preliminary Report.
Tafuri A; Sebben M; Pirozzi M; Processali T; Shakir A; Rizzetto R; Amigoni N; Tiso L; De Michele M; Panunzio A; Cerrato C; Migliorini F; Novella G; De Marco V; Siracusano S; Artibani W; Porcaro AB
Urol Int; 2020; 104(5-6):465-475. PubMed ID: 31991418
[TBL] [Abstract] [Full Text] [Related]
18. Inhibition of hypoxia-inducible factor 1α accumulation by glyceryl trinitrate and cyclic guanosine monophosphate.
Kim J; Barsoum IB; Loh H; Paré JF; Siemens DR; Graham CH
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31912870
[TBL] [Abstract] [Full Text] [Related]
19. Addition of radium-223 to abiraterone acetate and prednisone or prednisolone in patients with castration-resistant prostate cancer and bone metastases (ERA 223): a randomised, double-blind, placebo-controlled, phase 3 trial.
Smith M; Parker C; Saad F; Miller K; Tombal B; Ng QS; Boegemann M; Matveev V; Piulats JM; Zucca LE; Karyakin O; Kimura G; Matsubara N; Nahas WC; Nolè F; Rosenbaum E; Heidenreich A; Kakehi Y; Zhang A; Krissel H; Teufel M; Shen J; Wagner V; Higano C
Lancet Oncol; 2019 Mar; 20(3):408-419. PubMed ID: 30738780
[TBL] [Abstract] [Full Text] [Related]
20. Early Catheter Removal After Robot-assisted Radical prostatectomy: Results from a Prospective Single-institutional Randomized Trial (Ripreca Study).
Lista G; Lughezzani G; Buffi NM; Saita A; Vanni E; Hurle R; Cardone P; Peschechera R; Forni G; Lazzeri M; Guazzoni G; Casale P
Eur Urol Focus; 2020 Mar; 6(2):259-266. PubMed ID: 30413390
[TBL] [Abstract] [Full Text] [Related]
[Next]
